Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy

Table 4 Awarded points for VTS score

	0 points	0.5 points	1 point
Cumulative brain metastases volume	> 1.5 cc	< 1.5 cc
Timing	synchronous	metachronous
Systemic treatment	targeted therapy		immunotherapy

ISSN: 1748-717X